Viemed Healthcare (NASDAQ:VMD - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.08 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.08, Zacks reports. The business had revenue of $63.06 million for the quarter, compared to analysts' expectations of $63.50 million. Viemed Healthcare had a return on equity of 10.56% and a net margin of 5.80%.
Viemed Healthcare Trading Up 1.9%
VMD stock traded up $0.14 on Friday, reaching $7.10. The company's stock had a trading volume of 270,308 shares, compared to its average volume of 165,651. The firm has a market cap of $280.39 million, a PE ratio of 20.85 and a beta of 1.33. The business has a fifty day simple moving average of $6.66 and a two-hundred day simple moving average of $7.09. Viemed Healthcare has a 12-month low of $5.93 and a 12-month high of $9.81. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.26 and a current ratio of 1.38.
Insider Activity at Viemed Healthcare
In other Viemed Healthcare news, Director Nitin Kaushal sold 34,100 shares of the firm's stock in a transaction on Friday, June 27th. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00. Following the completion of the transaction, the director owned 126,843 shares of the company's stock, valued at approximately $889,169.43. This trade represents a 21.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 20.00% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of VMD. Geode Capital Management LLC raised its holdings in shares of Viemed Healthcare by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 798,515 shares of the company's stock worth $5,519,000 after acquiring an additional 15,353 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Viemed Healthcare during the 1st quarter valued at about $394,000. Finally, AQR Capital Management LLC bought a new position in shares of Viemed Healthcare in the 1st quarter valued at about $90,000. 74.24% of the stock is owned by institutional investors.
Viemed Healthcare Company Profile
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.